Skip to content
← Back to this collection

PUBLICATIONS · 12648074

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2003 Mar
First author
Hellström-Lindberg E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hellström-Lindberg E
      type
      Author
    2. name
      Gulbrandsen N
      type
      Author
    3. name
      Lindberg G
      type
      Author
    4. name
      Ahlgren T
      type
      Author
    5. name
      Dahl IM
      type
      Author
    6. name
      Dybedal I
      type
      Author
    7. name
      Grimfors G
      type
      Author
    8. name
      Hesse-Sundin E
      type
      Author
    9. name
      Hjorth M
      type
      Author
    10. name
      Kanter-Lewensohn L
      type
      Author
    11. name
      Linder O
      type
      Author
    12. name
      Luthman M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hellström-Lindberg E
      type
      Author
    2. name
      Gulbrandsen N
      type
      Author
    3. name
      Lindberg G
      type
      Author
    4. name
      Ahlgren T
      type
      Author
    5. name
      Dahl IM
      type
      Author
    6. name
      Dybedal I
      type
      Author
    7. name
      Grimfors G
      type
      Author
    8. name
      Hesse-Sundin E
      type
      Author
    9. name
      Hjorth M
      type
      Author
    10. name
      Kanter-Lewensohn L
      type
      Author
    11. name
      Linder O
      type
      Author
    12. name
      Luthman M
      type
      Author
    bibliography ids
    1. nci-bib-ae123bd141d70182b51f5583
    book metadata
    content sha256
    0f480dcbb88a70450a5f4d1c1ae1e1707089b63ceefc4a6f48eba3d02799939d
    document type
    citation
    dois
    1. 10.1046/j.1365-2141.2003.04153.x
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:12648074
    immutable id
    pubmed:12648074@0f480dcbb88a70450a5f4d1c1ae1e1707089b63ceefc4a6f48eba3d02799939d
    journal
    abbreviation
    Br J Haematol
    issn electronic
    Source null
    issn print
    0007-1048
    issue
    6
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    1037-46
    volume
    120
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      12648074
      provenance
      batch id
      6646708a43dc2007bef0
      provider
      NCBI PubMed ESummary
      record sha256
      35aa41b78686dcf810b087d1ac0e34a2cdf8d70d829f4577ca7de1badcb6cbd4
      response sha256
      2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
      retrieved at
      2026-09-09T23:45:48.511831+00:00
      publication date
      display
      2003 Mar
      precision
      month
      year
      2003
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/12648074/
      title
      A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.

      Preserved source evidence · Not medical advice